Capital Planning
ABBV icon

Capital Planning’s AbbVie ABBV Stock Holding History

Capital Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.12M Sell
11,916
-7,500
-39% -$1.92M 0.83% 27
2026
Q2 		$4.89M Buy
19,416
+3,430
+21% +$738K 1.42% 23
2026
Q1 		$3.48M Hold
15,986
– – 1.13% 27
2025
Q4 		$3.67M Hold
15,986
– – 1.03% 28
2025
Q3 		$3.7M Buy
15,986
+14,831
+1,284% +$3.02M 1.08% 26
2025
Q2 		$214K Sell
1,155
-5,000
-81% -$929K 0.07% 79
2025
Q1 		$1.29M Sell
6,155
-84
-1% -$16.3K 0.36% 44
2024
Q4 		$1.11M Buy
6,239
+105
+2% +$19.3K 0.29% 44
2024
Q3 		$1.21M Buy
6,134
+50
+0.8% +$9.33K 0.34% 40
2024
Q2 		$1.04M Hold
6,084
– – 0.31% 41
2024
Q1 		$1.11M Buy
6,084
+934
+18% +$161K 0.36% 40
2023
Q4 		$798K Hold
5,150
– – 0.28% 46
2023
Q3 		$768K Hold
5,150
– – 0.3% 48
2023
Q2 		$694K Hold
5,150
– – 0.27% 46
2023
Q1 		$821K Hold
5,150
– – 0.34% 43
2022
Q4 		$832K Hold
5,150
– – 0.37% 48
2022
Q3 		$691K Sell
5,150
-2,854
-36% -$410K 0.39% 35
2022
Q2 		$1.23M Sell
8,004
-610
-7% -$93.2K 0.66% 30
2022
Q1 		$1.4M Hold
8,614
– – 0.54% 30
2021
Q4 		$1.17M Hold
8,614
– – 0.43% 38
2021
Q3 		$929K Sell
8,614
-42
-0.5% -$4.8K 0.38% 37
2021
Q2 		$975K Sell
8,656
-282
-3% -$31.8K 0.41% 38
2021
Q1 		$967K Sell
8,938
-428
-5% -$45.8K 0.43% 38
2020
Q4 		$1M Buy
+9,366
New +$900K 0.47% 38

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Capital Planning's ABBV Position: Q3 2026 in Review

Capital Planning reduced its AbbVie (ABBV) stake by 39% in Q3 2026, selling an estimated $1.92M and leaving 11,916 shares worth $3.12M. The position accounts for 0.83% of the portfolio, ranked #27.

Capital Planning first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $4.89M in Q2 2026. 1,944 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Capital Planning held 11,916 shares of AbbVie worth $3.12M as of Q3 2026.
  • Capital Planning sold 7,500 AbbVie shares in Q3 2026, an estimated $1.92M.
  • AbbVie made up 0.83% of Capital Planning's portfolio in Q3 2026, its #27 holding.
  • Capital Planning first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • Capital Planning's AbbVie position peaked at $4.89M in Q2 2026.
  • 1,944 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Capital Planning's 13F filing for Q3 2026, filed 9 Oct 2026.